Davide Torti

2.0k total citations
17 papers, 677 citations indexed

About

Davide Torti is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Davide Torti has authored 17 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Hematology and 5 papers in Genetics. Recurrent topics in Davide Torti's work include Chronic Myeloid Leukemia Treatments (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Davide Torti is often cited by papers focused on Chronic Myeloid Leukemia Treatments (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Davide Torti collaborates with scholars based in Italy, United States and United Kingdom. Davide Torti's co-authors include Livio Trusolino, Andrea Bertotti, Francesco Galimi, Paolo M. Comoglio, Francesco Sassi, Angelo Guerrasio, Giuseppe Saglio, Giovanna Carrà, Sabrina Crivellaro and Cristina Panuzzo and has published in prestigious journals such as Oncogene, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Davide Torti

17 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Davide Torti Italy 12 418 304 137 116 90 17 677
Dan Lu China 9 458 1.1× 203 0.7× 131 1.0× 85 0.7× 70 0.8× 16 694
Shane K. Green Canada 7 462 1.1× 378 1.2× 233 1.7× 117 1.0× 60 0.7× 9 795
Zizhen Feng China 12 671 1.6× 272 0.9× 145 1.1× 140 1.2× 114 1.3× 23 1.0k
Raymond Wadlow United States 14 484 1.2× 485 1.6× 196 1.4× 179 1.5× 43 0.5× 36 944
Maïa Chanrion France 7 513 1.2× 231 0.8× 196 1.4× 86 0.7× 117 1.3× 9 751
Yong Xian United States 9 473 1.1× 210 0.7× 76 0.6× 49 0.4× 103 1.1× 9 726
P.N. Munster United States 12 307 0.7× 336 1.1× 79 0.6× 119 1.0× 31 0.3× 18 584
Oriol Arpí Spain 15 359 0.9× 376 1.2× 149 1.1× 126 1.1× 64 0.7× 24 710
Dongyin Yu United States 7 498 1.2× 194 0.6× 151 1.1× 82 0.7× 23 0.3× 9 685
Jennifer Gauvin United States 9 352 0.8× 141 0.5× 65 0.5× 99 0.9× 44 0.5× 11 529

Countries citing papers authored by Davide Torti

Since Specialization
Citations

This map shows the geographic impact of Davide Torti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Torti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Torti more than expected).

Fields of papers citing papers by Davide Torti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Torti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Torti. The network helps show where Davide Torti may publish in the future.

Co-authorship network of co-authors of Davide Torti

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Torti. A scholar is included among the top collaborators of Davide Torti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Torti. Davide Torti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Fabbri, Andrea, Giuseppe Carpinteri, A Soldi, et al.. (2018). Methoxyflurane Versus Standard of Care for Acute Trauma-Related Pain in the Emergency Setting: Protocol for a Randomised, Controlled Study in Italy (MEDITA). Advances in Therapy. 36(1). 244–256. 10 indexed citations
2.
Carrà, Giovanna, Cristina Panuzzo, Davide Torti, et al.. (2017). Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones. Oncotarget. 8(22). 35508–35522. 59 indexed citations
3.
Morotti, Alessandro, Davide Torti, Giovanna Carrà, et al.. (2016). Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia. Current Drug Targets. 18(4). 389–395. 3 indexed citations
4.
Carrà, Giovanna, Cristina Panuzzo, Davide Torti, et al.. (2016). Inhibition OF USP7 Induces Selective Cancer Cell Death in Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 16. S49–S50. 1 indexed citations
5.
Carrà, Giovanna, Davide Torti, Sabrina Crivellaro, et al.. (2016). The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias. Oncotarget. 7(40). 66287–66298. 27 indexed citations
7.
Morotti, Alessandro, Cristina Panuzzo, Sabrina Crivellaro, et al.. (2015). The Role of PTEN in Myeloid Malignancies. Hematology Reports. 7(4). 6027–6027. 29 indexed citations
8.
Crivellaro, Sabrina, Cristina Panuzzo, Giovanna Carrà, et al.. (2015). Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion. Oncotarget. 6(28). 25217–25225. 15 indexed citations
9.
Carrà, Giovanna, Cristina Panuzzo, Davide Torti, et al.. (2015). Therapeutic inhibition of HAUSP-PTEN network in chronic lymphocytic leukemia. Clinical Lymphoma Myeloma & Leukemia. 15. S25–S25. 1 indexed citations
10.
Panuzzo, Cristina, Gisella Volpe, Sabrina Crivellaro, et al.. (2015). New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia. Oncoscience. 2(10). 880–891. 2 indexed citations
11.
Cilloni, Daniela, Sonia Carturan, Enrico Bracco, et al.. (2013). Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia. Leukemia Research. 37(5). 520–530. 13 indexed citations
12.
Migliardi, Giorgia, Francesco Sassi, Davide Torti, et al.. (2012). Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas. Clinical Cancer Research. 18(9). 2515–2525. 147 indexed citations
13.
Sassi, Francesco, Paolo Accornero, Davide Torti, et al.. (2012). Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. Oncogene. 32(11). 1428–1440. 54 indexed citations
14.
Torti, Davide, Francesco Sassi, Francesco Galimi, et al.. (2011). A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors. International Journal of Cancer. 130(6). 1357–1366. 18 indexed citations
15.
Torti, Davide & Livio Trusolino. (2011). Oncogene addiction as a foundational rationale for targeted anti‐cancer therapy: promises and perils. EMBO Molecular Medicine. 3(11). 623–636. 169 indexed citations
16.
Bertotti, Andrea, Flavia Girolami, Davide Torti, et al.. (2010). Inhibition of Src Impairs the Growth of Met-Addicted Gastric Tumors. Clinical Cancer Research. 16(15). 3933–3943. 38 indexed citations
17.
Bertotti, Andrea, Mike F. Burbridge, Stefania Gastaldi, et al.. (2009). Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction. Science Signaling. 2(100). er11–er11. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026